A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.

Xiaoyan Si,Jinwan Wang,Ying Cheng,Jianhua Shi,Liying Cui,Helong Zhang,Y. Huang,Wei Liu,Lei Chen,Jiang Zhu,Shucai Zhang,Wei Li,Yan Sun,Hanping Wang,Xiaotong Zhang,Mengzhao Wang,Lin Yang,Li Zhang

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.

2020

Xiaoyan Si
Jinwan Wang
Ying Cheng
Jianhua Shi
Liying Cui
Helong Zhang
Y. Huang
Wei Liu
Lei Chen
Jiang Zhu
Shucai Zhang
Wei Li
Yan Sun
Hanping Wang
Xiaotong Zhang
Mengzhao Wang
Lin Yang
Li Zhang

Background:Carboxyamidotriazole (CAI), a calcium channel blocker, inhibits tumor cell proliferation, metastasis, and angiogenesis. This trial aimed to determine whether CAI combined with convention...

Keywords:

Angiogenesis
Lung cancer
Oncology
Internal medicine
Carboxyamidotriazole
Chemotherapy
Medicine
Cisplatin
Metastasis
Vinorelbine
Calcium channel blocker

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations